These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2150477)

  • 1. [Racemic and optically active 2-chloroethylcarbamoyl derivatives of 7,8-dimethoxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine: a new structural type of DA, NE and 5-T uptake inhibitors].
    Mondeshka D; Angelova I; Ivanov CB; Ivanova NS
    Arch Pharm (Weinheim); 1990 Oct; 323(10):829-32. PubMed ID: 2150477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antiulcer and antidepressive activity of 4-(4-halophenyl)-2-phenyl-1,2,3,4-tetrahydroisoquinolines.
    Mondeshka DM; Angelova IG; Tancheva CN; Ivanov CB; Daleva LD; Ivanova NS
    Farmaco; 1994; 49(7-8):475-80. PubMed ID: 7945712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.
    Froimowitz M; Wu KM; Moussa A; Haidar RM; Jurayj J; George C; Gardner EL
    J Med Chem; 2000 Dec; 43(26):4981-92. PubMed ID: 11150168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals.
    Xu K; Näveri L; Frerichs KU; Hallenbeck JM; Feuerstein G; Davis JN; Sirén AL
    J Pharmacol Exp Ther; 1993 Oct; 267(1):211-7. PubMed ID: 7901393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake.
    Bøgesø KP; Christensen AV; Hyttel J; Liljefors T
    J Med Chem; 1985 Dec; 28(12):1817-28. PubMed ID: 2999402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
    Johnson MP; Conarty PF; Nichols DE
    Eur J Pharmacol; 1991 Jul; 200(1):9-16. PubMed ID: 1685125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
    Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
    Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
    Heffernan GD; Coghlan RD; Manas ES; McDevitt RE; Li Y; Mahaney PE; Robichaud AJ; Huselton C; Alfinito P; Bray JA; Cosmi SA; Johnston GH; Kenney T; Koury E; Winneker RC; Deecher DC; Trybulski EJ
    Bioorg Med Chem; 2009 Nov; 17(22):7802-15. PubMed ID: 19836247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
    Zheng YY; Gao K; Weng ZJ; Li JQ
    Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
    Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
    J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.
    McComas CC; Vu AT; Mahaney PE; Cohn ST; Fensome A; Marella MA; Nogle L; Trybulski EJ; Ye F; Zhang P; Alfinito P; Bray J; Johnston G; Koury E; Deecher DC
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4929-31. PubMed ID: 18771916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers.
    Reith ME; Li MY; Yan QS
    Psychopharmacology (Berl); 1997 Dec; 134(3):309-17. PubMed ID: 9438681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Naphthyl and 4-indolyl arylalkylamines as selective monoamine reuptake inhibitors.
    Manning JR; Sexton T; Childers SR; Davies HM
    Bioorg Med Chem Lett; 2009 Jan; 19(1):58-61. PubMed ID: 19038547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological and behavioral analysis of the effects of some bivalent ligand-based monoamine reuptake inhibitors.
    Tamiz AP; Bandyopadhyay BC; Zhang J; Flippen-Anderson JL; Zhang M; Wang CZ; Johnson KM; Tella S; Kozikowski AP
    J Med Chem; 2001 May; 44(10):1615-22. PubMed ID: 11334571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.
    Zhang P; Terefenko EA; McComas CC; Mahaney PE; Vu A; Trybulski E; Koury E; Johnston G; Bray J; Deecher D
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6067-70. PubMed ID: 18951020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and enantioselectivity of optically active 1- and 3-substituted 4-phenyl-1,2,3,4-tetrahydroisoquinolin-4-ols and related compounds as norepinephrine potentiators.
    Kihara M; Ikeuchi M; Adachi S; Nagao Y; Moritoki H; Yamaguchi M; Taira Z
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1543-6. PubMed ID: 7586079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
    Imperato A; Di Chiara G
    Eur J Pharmacol; 1988 Nov; 156(3):385-93. PubMed ID: 2905668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.